Marktkapitalisierung, EUR | 13.661,12 Mio. |
Gewinn je Aktie, EUR | -7,87 |
KBV | 3,87 |
KGV | - |
Dividendenrendite | 0,00% |
Umsatz, EUR | 2.274,33 Mio. |
Jahresüberschuss, EUR | -815,57 Mio. |
Gewinnmarge | -35,86% |
ETF | Gewichtung | Anlagefokus | Titel | TER | Fondsgröße Mio. EUR | Rendite 1J | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 0,99% | Aktien Welt Gesundheitswesen Gleichgewichtet/Equal Weighted Innovation | 217 | 0,59% | 15 | -12,86% | A2PFPC | IE00BJQTJ848 |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0,75% | Aktien Welt Gesundheitswesen Sozial/Nachhaltig Innovation | 95 | 0,30% | 3 | -7,60% | DBX0R2 | IE000KD0BZ68 |
iShares Dow Jones China Offshore 50 UCITS ETF (DE) | 1,01% | Aktien China | 50 | 0,61% | 52 | -8,42% | A0F5UE | DE000A0F5UE8 |
Xtrackers Emerging Markets Net Zero Pathway Paris Aligned UCITS ETF | 0,19% | Aktien Emerging Markets Sozial/Nachhaltig Klimawandel | 651 | 0,20% | 20 | +6,08% | DBX0ST | IE000TZT8TI0 |
First Trust NYSE Arca Biotechnology UCITS ETF Acc | 3,18% | Aktien USA Gesundheitswesen Biotechnologie | 30 | 0,60% | 6 | -7,40% | A2PZBP | IE00BL0L0H60 |
JPMorgan Carbon Transition China Equity (CTB) UCITS ETF | 0,18% | Aktien China Sozial/Nachhaltig Klimawandel | 219 | 0,35% | 6 | -10,34% | A3DUAK | IE000G3A6RN7 |
Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 0,47% | Aktien USA Technologie | 104 | 0,25% | 40 | +10,18% | A2QPVX | IE00BMD8KP97 |
HSBC MSCI AC Asia Pacific ex Japan Climate Paris Aligned UCITS ETF | 0,00% | Aktien Asien-Pazifik Sozial/Nachhaltig Klimawandel | 368 | 0,25% | 15 | +3,40% | A3C8ZY | IE000XFORJ80 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0,46% | Aktien Welt Sozial/Nachhaltig Innovation | 361 | 0,60% | 4 | -0,31% | A3DHPA | IE000VTOHNZ0 |
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0,04% | Aktien Welt Multi-Faktor-Strategie | 3.070 | 0,50% | 36 | - | WELT0B | IE000FPWSL69 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0,71% | Aktien USA Gesundheitswesen Biotechnologie | 222 | 0,35% | 34 | -1,19% | A2JDYM | IE00BDZVHG35 |
Amundi Prime Emerging Markets UCITS ETF DR (C) | 0,12% | Aktien Emerging Markets | 1.362 | 0,10% | 26 | +10,91% | A3CM5D | LU2300295123 |
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0,04% | Aktien Welt Multi-Faktor-Strategie | 3.070 | 0,50% | 188 | - | WELT0A | IE0001UQQ933 |
iShares Nasdaq US Biotechnology UCITS ETF | 0,71% | Aktien USA Gesundheitswesen Biotechnologie | 222 | 0,35% | 410 | -1,07% | A2DWAW | IE00BYXG2H39 |
Amundi Prime All Country World UCITS ETF DIST (D) | 0,06% | Aktien Welt | 1.109 | 0,07% | 95 | - | ETF150 | IE0009HF1MK9 |
L&G Pharma Breakthrough UCITS ETF | 2,91% | Aktien Welt Gesundheitswesen Innovation | 32 | 0,49% | 16 | -19,85% | A2H9XR | IE00BF0H7608 |
L&G Emerging Markets ESG Exclusions Paris Aligned UCITS ETF USD Accumulating | 0,14% | Aktien Emerging Markets Sozial/Nachhaltig Klimawandel | 1.180 | 0,25% | 80 | - | A3DNYX | IE000CBYU7J5 |
Bank | Testurteil | Gebühr pro Sparrate | Depotgebühr | Mehr Informationen |
---|---|---|---|---|
EUR 1,50 1,50% | kostenlos | Mehr Infos* |